Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma

Evaluation of NTRK Gene Fusion by Five Different Platforms in Triple-Negative Breast Carcinoma

Triple-negative breast carcinoma (TNBC) is an aggressive disease that has a poor prognosis since it lacks effective treatment methods. Neurotrophic tyrosine receptor kinase (NTRK) fusion genes are excellent candidates for targeted RTK inhibitor therapies and there are available targeted therapy drug...

Full description

Bibliographic Details
Main Authors: Shafei Wu, Xiaohua Shi, Xinyu Ren, Kaimi Li, Junyi Pang, Zhiyong Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
IHC
NGS
RT-PCR
FISH
NTRK fusion gene
triple-negative breast carcinoma
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2021.654387/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2021.654387/full

Similar Items